BioCatalystWatch
ALVOWorkspace / ALVO / OverviewCompany library
Alvotech logo

Alvotech

Alvotech (ALVO)

Website

Featured programme · AVT29

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

VEGF

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

AVT29

VEGF

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

VEGF

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

AVT29

VEGF

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

AVT16

α4β7 integrin

PreINDP1P2P3FilingApproved
AVT16

AVT10

TNF-α

PreINDP1P2P3FilingApproved

Approved / commercial

TNF-α

Approved

PreINDP1P2P3FilingApproved

TNF-α

Approved

PreINDP1P2P3FilingApproved

TNF-α

Approved

PreINDP1P2P3FilingApproved

TNF-α

Approved

PreINDP1P2P3FilingApproved

TNF-α

Approved

PreINDP1P2P3FilingApproved

TNF-α

Approved

PreINDP1P2P3FilingApproved

TNF-α

Approved

PreINDP1P2P3FilingApproved

TNF-α

Approved

PreINDP1P2P3FilingApproved

History / paused

AVT16

α4β7 integrin

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ALVO SEC archive